Eid et al. review the current state of knowledge of diabetic peripheral neuropathy, emphasizing how hyperglycemia and dyslipidemia, against the backdrop of the unique peripheral nerve anatomy, drive bioenergetics failure and injury. Axoglial interactions, pain mechanisms, and rationale-based treatment approaches are also covered.